iCST Web-application for People With Dementia
Launched by UNIVERSITY OF NOTTINGHAM · Sep 13, 2017
Trial Information
Current as of May 26, 2025
Completed
Keywords
ClinConnect Summary
Scientific justification:
Since the use of technology is rapidly increasing in every aspect of many people's daily lives, previous research has already begun to investigate its application and implementation in multiple areas within dementia care. An example of an area where technology and dementia come together is computerised cognitive interventions. These types of interventions build on the added benefits of computer use such as reduced cognitive decline in older adults and lower risk of receiving a diagnosis of dementia among older men with the added benefits of using one's cognitive c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Person with dementia:
- • Meet Diagnostic and Statistical Manual of Mental Disorders (DSM IV) criteria for dementia (American Psychiatric Association, 2013).
- • Score 10 or above on the Mini Mental State Examination (MMSE) (Folstein, Folstein, \& McHugh, 1975) or score of 16 or above on the Montreal Cognitive Assessment (MoCA) (Trzepacz et al., 2015) where available.
- • Some ability to communicate and understand (e.g. ability to give informed consent)
- • Ability to speak and understand English
- • See/hear well enough to participate
- • No major physical illness or disability affecting their participation
- • Age range: 50 years - no maximum age limit
- • Availability of a tablet to the person with dementia and carer
- • Availability of a carer (or friend/befriender) to participate in the focus groups, interviews and iCST web-app sessions
- Carer:
- • Minimum age: 21
- • Ability to speak and understand English
- • See/hear well enough to participate
- • No major physical illness or disability affecting their participation
- • Exclusion criteria
- Person with dementia and carer:
- • - Concurrent participation in any other interventional study for people with dementia/carers
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Derby, Derbyshire, United Kingdom
Leicester, Leicestershire, United Kingdom
Lincoln, Lincolnshire, United Kingdom
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Trial Officials
Martin Orrell, MD, PhD
Study Chair
University of Nottingham
Justine Schneider, PhD
Study Director
University of Nottingham
Harleen Rai, MSc.
Principal Investigator
University of Nottingham
Lauren Yates, PhD
Study Director
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials